Assessing the potential protective effects of tirzepatide against renal ischaemia-reperfusion injury in male rats: inhibition of Foxo1 expression and pyroptosis

Authors

  • Hajir Karim Abdul-Husseein
  • Fatima Adnan Alzubaidi

DOI:

https://doi.org/10.60988/p.v37i2S.138

Keywords:

tirzepatide; renal ischaemia-reperfusion injury; FOXO1; KIM-1; pyroptosis

Abstract

Renal ischaemia-reperfusion injury (RIRI) is a significant contributing factor to acute kidney injury, characterized by inflammation and oxidative stress formation that delay tissue repair. Our study has assessed the nephroprotective effects of tirzepatide on RIRI, through its effect on the forkhead box O1 gene (Foxo1) expression and pyroptosis in male rats. Our study included 24 Wistar rats divided to four groups (n=6 each): a sham group (without an induction of RIRI), a control group (with an induction of RIRI), a vehicle group (receiving an intraperitoneal injection of dimethyl sulfoxide at 1 mg/kg, 1 h before ischaemia), and a tirzepatide-treated group (receiving an intraperitoneal injection of tirzepatide at 1.35 mg/kg, 1 h before ischaemia). Our results revealed that tirzepatide can significantly reduce the kidney injury molecule-1 levels (p=0.027) and the levels of pyroptosis markers caspase-1 (p<0.001) and caspase-11 (p=0.005) in the studied rats’ kidneys. Histopathological analysis of the latter revealed severe injury in the control group, while tirzepatide-treated rats exhibited injury scores under 40%. Additionally, the Foxo1 expression was found to be significantly reduced as a result of the tirzepatide treatment (p=0.031). We concluded that tirzepatide may potentially relieve ischaemic renal damage through the modulation of pyroptosis and inflammatory pathways, thereby highlighting its potential as a targeted therapy for RIRI.

Author Biographies

Hajir Karim Abdul-Husseein

Department of Clinical Pharmacy, College of Pharmacy, University of Babylon, Hillah, Iraq

Fatima Adnan Alzubaidi

Department of Clinical Pharmacy, College of Pharmacy, University of Babylon, Hillah, Iraq

References

Mahmood K.A., Ewadh M.J., Al-Saad S.F. Assessment of cystatin C and CCL14 as predictive and diagnostic biomarkers for contrast-induced nephropathy. Regul. Mech. Biosyst. 15(3), 610–612, 2024. DOI: 10.15421/022486

Jallawee Q.H., Janabi A.M. Trandolapril improves renal ischemia-reperfusion injury in adult male rats via activation of the autophagy pathway and inhibition of inflammation, oxidative stress, and apoptosis. J. Biosci. Appl. Res. 10(6), 114–127, 2024. DOI: 10.21608/jbaar.2024.315239.1077

Yin F., Zheng P.Q., Zhao L.Q., Wang Y.Z., Miao N.J., Zhou Z.L., et al. Caspase-11 promotes NLRP3 inflammasome activation via the cleavage of pannexin1 in acute kidney disease. Acta Pharmacol. Sin. 43(1), 86–95, 2022. DOI: 10.1038/s41401-021-00619-2

Zhao G., Li H., Zhang H., Xiao K., Yang H., Li Z., et al. m6A methylase WTAP participates in renal ischemia-reperfusion injury by regulating FOXO1 expression. Nan Fang Yi Ke Da Xue Xue Bao 43(12), 2035–2042, 2023. DOI: 10.12122/j.issn.1673-4254.2023.12.07

Lasorsa F., Rutigliano M., Milella M., d’Amati A., Crocetto F., Pandolfo S.D., et al. Ischemia-reperfusion injury in kidney transplantation: mechanisms and potential therapeutic targets. Int. J. Mol. Sci. 25(8), 4332, 2024. DOI: 10.3390/ijms25084332

Alathary A.J., Kadhim Z.J. Tirzepatide protects against hepatic oxidative stress in high-fat induced obesity in male rats. Maaen J. Med. Sci. 3(3), 6, 2024. DOI: 10.55810/2789-9136.1053

Taktaz F., Fontanella R.A., Scisciola L., Pesapane A., Basilicata M.G., Ghosh P., et al. Bridging the gap between GLP1-receptor agonists and cardiovascular outcomes: evidence for the role of tirzepatide. Cardiovasc. Diabetol. 23(1), 242, 2024. DOI: 10.1186/s12933-024-02319-7

Tutunea-Fatan E., Arumugarajah S., Suri R.S., Edgar C.R., Hon I., Dikeakos J.D., et al. Sensing dying cells in health and disease: the importance of kidney injury molecule-1. J. Am. Soc. Nephrol. 35(6), 795–808, 2024. DOI: 10.1681/ASN.0000000000000334

Al-Mubarak B., Soriano F.X., Hardingham G.E. Synaptic NMDAR activity suppresses FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. Channels (Austin) 3(4), 233–238, 2009. DOI: 10.4161/chan.3.4.9381

Song J., Li Z., Zhou L., Chen X., Sew W.Q.G., Herranz H., et al. FOXO-regulated OSER1 reduces oxidative stress and extends lifespan in multiple species. Nat. Commun. 15(1), 7144, 2024. DOI: 10.1038/s41467-024-51542-z

Downloads

Published

10-10-2025

How to Cite

[1]
Abdul-Husseein, H.K. and Adnan Alzubaidi, F. 2025. Assessing the potential protective effects of tirzepatide against renal ischaemia-reperfusion injury in male rats: inhibition of Foxo1 expression and pyroptosis. Pharmakeftiki . 37, 2S (Oct. 2025). DOI:https://doi.org/10.60988/p.v37i2S.138.